11/01/2025 06:25:20
11/02/2022 17:00:00
11/02/2022 18:00:00
Participate in this live event
Register with your My PCR account, add it to your calendar and receive automatic reminders.
Please log into your MyPCR account before proceeding
Coordinators:
Speakers:
Objectives:
Join this webinar if you want to:
- learn about the prevalence, causes and prognosis of heart failure and tricuspid regurgitation
- understand the importance of early identification of tricuspid regurgitation in patients with heart failure
- learn about the limitations of medical therapies in the management of patients with isolated tricuspid regurgitation and the role of transcatheter therapies
Upcoming webinars in this series
Introducing the PCR Tricuspid Focus Group
The Focus Group is committed to fostering the establishment of tricuspid therapies, improving outcomes, and delivering sustainable clinical solutions for complex patients. Discover an overview of the new initiative’s mission and five ongoing working groups dedicated to improving the treatment of patients with tricuspid valve disease
This webinar is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of External CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational activity.
With M. Adamo, M. Metra, O. Chioncel, A. Coats, J. Grapsa, P. Lurz and G. Rosano.
Thank you for watching the webinar
To download your certificate of attendance and get your CME credits, please complete the quick satisfaction survey now!
Access hereCoordinators:
Speakers:
Objectives:
Watch the replay of this webinar if you want to:
- learn about the prevalence, causes and prognosis of heart failure and tricuspid regurgitation
- understand the importance of early identification of tricuspid regurgitation in patients with heart failure
- learn about the limitations of medical therapies in the management of patients with isolated tricuspid regurgitation and the role of transcatheter therapies
Upcoming webinars in this series
Introducing the PCR Tricuspid Focus Group
The Focus Group is committed to fostering the establishment of tricuspid therapies, improving outcomes, and delivering sustainable clinical solutions for complex patients. Discover an overview of the new initiative’s mission and five ongoing working groups dedicated to improving the treatment of patients with tricuspid valve disease